41 related articles for article (PubMed ID: 32864684)
1. Prognostic value of PD-L1 combined positive score in patients with upper tract urothelial carcinoma.
Chen CH; Tsai MY; Chiang PC; Sung MT; Luo HL; Suen JL; Tsai EM; Chiang PH
Cancer Immunol Immunother; 2021 Oct; 70(10):2981-2990. PubMed ID: 33740124
[TBL] [Abstract][Full Text] [Related]
2. A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing.
Angeloni M; van Doeveren T; Lindner S; Volland P; Schmelmer J; Foersch S; Matek C; Stoehr R; Geppert CI; Heers H; Wach S; Taubert H; Sikic D; Wullich B; van Leenders GJ; Zaburdaev V; Eckstein M; Hartmann A; Boormans JL; Ferrazzi F; Bahlinger V
J Pathol Clin Res; 2024 Mar; 10(2):e12369. PubMed ID: 38504364
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.
Mizuno T; Kamai T; Tsuzuki T; Nishihara D; Kijima T; Arai K; Yoshida KI
Cancer Immunol Immunother; 2022 Mar; 71(3):565-578. PubMed ID: 34275008
[TBL] [Abstract][Full Text] [Related]
4. Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments.
Rüschoff J; Kumar G; Badve S; Jasani B; Krause E; Rioux-Leclercq N; Rojo F; Martini M; Cheng L; Tretiakova M; Mitchell C; Anders RA; Robert ME; Fahy D; Pyle M; Le Q; Yu L; Glass B; Baxi V; Babadjanova Z; Pratt J; Brutus S; Karasarides M; Hartmann A
Virchows Arch; 2024 Apr; 484(4):597-608. PubMed ID: 38570364
[TBL] [Abstract][Full Text] [Related]
5. Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma.
Kdimati S; Christoph C; Glass Ä; Engel N; Dräger DL; Maletzki C; Becker AS; Zimpfer A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542462
[TBL] [Abstract][Full Text] [Related]
6. Alix-normalized exosomal programmed death-ligand 1 analysis in urine enables precision monitoring of urothelial cancer.
Woo HK; Park J; Kim KH; Ku JY; Ha HK; Cho YK
Cancer Sci; 2024 May; 115(5):1602-1610. PubMed ID: 38480462
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer.
Kosova I; Barsegian V; Gundorova L; Kolbasov D
Int Urogynecol J; 2024 May; 35(5):1069-1075. PubMed ID: 38662109
[TBL] [Abstract][Full Text] [Related]
8. Increased Apolipoprotein A1 Expression Correlates with Tumor-Associated Neutrophils and T Lymphocytes in Upper Tract Urothelial Carcinoma.
Chang CC; Chang CB; Chen CJ; Tung CL; Hung CF; Lai WH; Shen CH; Tsai CY; Lai YY; Lee MY; Wu SF; Chen PC
Curr Issues Mol Biol; 2024 Mar; 46(3):2155-2165. PubMed ID: 38534755
[TBL] [Abstract][Full Text] [Related]
9. Spatial relationship of tertiary lymphoid structures and tumor-associated neutrophils in bladder cancer and prognostic potential for anti-PD-L1 immunotherapy.
Wang X; Juncker-Jensen A; Huang G; Nagy ML; Lu X; Cheng L; Lu X
Cancer Commun (Lond); 2024 Apr; 44(4):499-503. PubMed ID: 37864307
[No Abstract] [Full Text] [Related]
10. The journey of determining PD-L1 expression in muscle-invasive urothelial carcinoma.
Algaba F
Actas Urol Esp (Engl Ed); 2024 May; ():. PubMed ID: 38754731
[No Abstract] [Full Text] [Related]
11. Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder.
Ma G; Jia H; Zhang G; Liang Y; Dong X; Fu G; Wang X; Niu H
Oncologist; 2024 Feb; 29(2):e248-e258. PubMed ID: 37874923
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Positivity Associated With Presence of Tertiary Lymphoid Structures and High-Stage Disease in Upper Tract Urothelial Carcinoma.
Smith ME; Farahani SJ; Chao T; Palmer M; Arriola A; Lal P
Am J Clin Pathol; 2020 Nov; 154(6):802-810. PubMed ID: 32864684
[TBL] [Abstract][Full Text] [Related]
15. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma.
Skala SL; Liu TY; Udager AM; Weizer AZ; Montgomery JS; Palapattu GS; Siddiqui J; Cao X; Fields K; Abugharib AE; Soliman M; Hafez KS; Miller D; Lee CT; Alva A; Chinnaiyan AM; Morgan TM; Spratt DE; Jiang H; Mehra R
Eur Urol Focus; 2017 Oct; 3(4-5):502-509. PubMed ID: 28753826
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 Expression Reveals Significant Association With Squamous Differentiation in Upper Tract Urothelial Carcinoma.
Arriola AGP; Farahani SJ; Bhargava HK; Guzzo TJ; Brooks JSJ; Lal P
Am J Clin Pathol; 2019 May; 151(6):561-573. PubMed ID: 30776071
[TBL] [Abstract][Full Text] [Related]
17. B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.
Koyama Y; Morikawa T; Miyama Y; Miyakawa J; Kawai T; Kume H; Sawabe M; Ushiku T
Pathol Res Pract; 2020 Dec; 216(12):153219. PubMed ID: 33049447
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma].
Campedel L; Seisen T; Cussenot O; Comperat E; Varinot J; Rouprêt M; Cancel-Tassin G
Prog Urol; 2018 Dec; 28(16):900-905. PubMed ID: 30219646
[TBL] [Abstract][Full Text] [Related]
19. The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma.
Chen H; Wang M; Weng T; Wei Y; Liu C; Yang L; Ren K; Tang Y; Tang Z; Gou X
Urol Oncol; 2021 Nov; 39(11):743-753. PubMed ID: 34330653
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
